Literature DB >> 23074036

Global demethylation in loss of imprinting subtype of Wilms tumor.

Jackie L Ludgate1, Gwenn Le Mée, Ryuji Fukuzawa, Euan J Rodger, Robert J Weeks, Anthony E Reeve, Ian M Morison.   

Abstract

Epigenetic abnormalities at the IGF2/H19 locus play a key role in the onset of Wilms tumor. These tumors can be classified into three molecular subtypes depending on the events occurring at this locus: loss of imprinting (LOI), loss of heterozygosity (LOH), or retention of imprinting (ROI). As IGF2 LOI is a consequence of aberrant methylation, we hypothesized that this subtype of Wilms tumors might display global abnormalities of methylation. We therefore analyzed the methylation status of satellite DNA, as a surrogate for global methylation in 50 Wilms tumor patients. Satellite methylation was quantified by a methylation-sensitive quantitative PCR. We confirmed hypomethylation of both satellite α (Sat α) and satellite 2 (Sat 2) DNA in Wilms tumor samples compared with normal kidney. In addition, we found that LOI tumors, unlike ROI or LOH ones, showed concordant hypomethylation of both Sat α and Sat 2 DNA. This would suggest that the LOI subtype of Wilms tumor, which unlike other subtypes results from an epimutation, has a global deregulation of methylation mechanisms.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23074036     DOI: 10.1002/gcc.22017

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.

Authors:  Sara Karami; Gabriella Andreotti; Linda M Liao; Ruth M Pfeiffer; Stephanie J Weinstein; Mark P Purdue; Jonathan N Hofmann; Demetrius Albanes; Satu Mannisto; Lee E Moore
Journal:  Epigenetics       Date:  2015-02-03       Impact factor: 4.528

2.  Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.

Authors:  Emma Cazaly; Jac Charlesworth; Joanne L Dickinson; Adele F Holloway
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

3.  Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.

Authors:  Conrad V Fernandez; Elizabeth J Perlman; Elizabeth A Mullen; Yueh-Yun Chi; Thomas E Hamilton; Kenneth W Gow; Fernando A Ferrer; Douglas C Barnhart; Peter F Ehrlich; Geetika Khanna; John A Kalapurakal; Tina Bocking; Vicky Huff; Jing Tian; James I Geller; Paul E Grundy; James R Anderson; Jeffrey S Dome; Robert C Shamberger
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

4.  TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation.

Authors:  Sijia Fan; Jing Wang; Guangqing Yu; Fangjing Rong; Dawei Zhang; Chenxi Xu; Juan Du; Zhi Li; Gang Ouyang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2020-09-22       Impact factor: 5.157

Review 5.  The yin and yang of kidney development and Wilms' tumors.

Authors:  Peter Hohenstein; Kathy Pritchard-Jones; Jocelyn Charlton
Journal:  Genes Dev       Date:  2015-03-01       Impact factor: 11.361

6.  Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.

Authors:  Jocelyn Charlton; Richard D Williams; Mark Weeks; Neil J Sebire; Sergey Popov; Gordan Vujanic; William Mifsud; Marisa Alcaide-German; Lee M Butcher; Stephan Beck; Kathy Pritchard-Jones
Journal:  Genome Biol       Date:  2014-08-19       Impact factor: 13.583

7.  The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop.

Authors:  Mariana Maschietto; Jocelyn Charlton; Daniela Perotti; Paolo Radice; James I Geller; Kathy Pritchard-Jones; Mark Weeks
Journal:  Oncotarget       Date:  2014-09-30

8.  Gene expression profiling of solitary fibrous tumors.

Authors:  François Bertucci; Corinne Bouvier-Labit; Pascal Finetti; Philippe Metellus; José Adelaide; Karima Mokhtari; Dominique Figarella-Branger; Anne-Valérie Decouvelaere; Catherine Miquel; Jean-Michel Coindre; Daniel Birnbaum
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

9.  Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour.

Authors:  Jocelyn Charlton; Richard D Williams; Neil J Sebire; Sergey Popov; Gordan Vujanic; Tasnim Chagtai; Marisa Alcaide-German; Tiffany Morris; Lee M Butcher; Paul Guilhamon; Stephan Beck; Kathy Pritchard-Jones
Journal:  Genome Med       Date:  2015-02-02       Impact factor: 11.117

Review 10.  The role of epigenetics in kidney malignancies.

Authors:  Alfredo Harb-De la Rosa; Matthew Acker; Sanjaya Swain; Murugesan Manoharan
Journal:  Cent European J Urol       Date:  2015-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.